Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

June 20, 2020

An Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody H2 Mab-19 Exerts Antitumor Activity in Mouse Colon Cancer Xenografts

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
Yukinari KatoMika K Kaneko
June 9, 2020
Review
Open Access

IL-15 in the Combination Immunotherapy of Cancer

Frontiers in Immunology
Thomas A WaldmannKevin C Conlon
June 5, 2020

Multivalent antibody-recruiting macromolecules: linking increased binding affinities with enhanced innate immune killing

Chembiochem : a European Journal of Chemical Biology
Annemiek Uvyn, Bruno de Geest
June 3, 2020

A complement-mediated rat xenotransfusion model of platelet refractoriness

Molecular Immunology
Adrianne I EnosKenji M Cunnion
June 20, 2020
Review

Complement and the Kidney: An Overview

Advances in Chronic Kidney Disease
Joshua M Thurman
June 11, 2020
Review
Open Access

BCMA-Targeting Therapy: Driving a New Era of Immunotherapy in Multiple Myeloma

Cancers
Shih-Feng ChoYu-Tzu Tai
June 10, 2020
Open Access

Functional production of human antibody by the filamentous fungus Aspergillus oryzae

Fungal biology and biotechnology
Hung Hiep HuynhJun-Ichi Maruyama
June 23, 2020
Case Report
Open Access

Massive atelectasis by mucoid impaction in an asthma patient during treatment with anti-interleukin-5 receptor antibody

Respirology Case Reports
Takayuki TakimotoYoshikazu Inoue
June 13, 2020
Open Access

Enhanced NK-92 Cytotoxicity by CRISPR Genome Engineering Using Cas9 Ribonucleoproteins

Frontiers in Immunology
Rih-Sheng HuangSteven Lin
July 1, 2020
Preprint
Open Access

Next generation of anti-PD-L1 Atezolizumab with better anti-tumor efficacy in vivo

BioRxiv : the Preprint Server for Biology
M. LiLe Sun
June 1, 2020

Impact of mAb Aggregation on its Biological Activity: Rituximab as a Case Study

Journal of Pharmaceutical Sciences
Rohit BansalAnurag S Rathore

Sign up to follow this feed and discover related papers.

Related Feeds

Antibodies: Agglutination

Antibody-mediated agglutination is the clumping of cells in the presence of antibody, which binds multiple cells together. This enhances the clearance of pathogens. Find the latest research on antibody-mediated agglutination here.

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.

Antibody Development

Development of antibodies require integration of knowledge with respect to target antigen properties, antibody design criteria such as affinity, isotype selection, Fc domain engineering, and antibody cross-reactivity across species from the early stages of antibody development. Here is the latest research.


Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Antibody synthesis

Antibodies have various functions including neutralization of pathogens, tumor targeting, as well as its utility in biomedical research. Here is the latest research on antibody synthesis.

Antibody-Dependent Enhancement

Antibody-dependent enhancement of viral infection is the entry of virus into host cells mediated by antiviral antibodies interacting with Fc or complement receptors. This has been most extensively observed with the dengue virus. Find the latest research on antibody-dependent enhancement here.

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

B cell Tolerance

B cell tolerance is maintained through mechanisms that can reversibly or irreversibly silence autoreactive B lymphocytes. Here is the latest research.

© 2020 Meta ULC. All rights reserved
/feed-previews/antibody-dependent-cell-cytotoxicity/b7638cb0-0881-4f16-85a1-0c032049bdb1